title: [Morphological characteristic of erythrocytes in experimental hypervitaminosis A].
abstract: This investigation was aimed at the analysis of the shape and morpho-densitometric parameters of the erythrocytes in rats with experimental hypervitaminosis A. Male Wistar rats received 0.64 mg/g (1167 IU/g) of retinol palmitate (RP) in oil solution orally for 11 consecutive days. Rats fed oil alone and intact animals were used as control groups. At days 5 and 6 of the experiment, the first manifestations of hypervitaminosis A were observed (body mass loss, localized erythema and hemorrhages). In contrast to control groups, in rats with hypervitaminosis A, the area of erythrocyte cytoplasm decreased gradually in response to RP administration. Discocyte/spherocyte/stomatocyte ratio also changed dynamically: the proportion of discocytes progressively decreased, while the amount of spherocytes and stomatocytes increased. These results show that excess of the vitamin A alters the erythrocyte membrane structure. Integral optical density of erythrocyte cytoplasm in RP-treated rats as well as in oil-fed rats was lower than in intact animals. This may be an indirect evidence of the fall in erythrocyte hemoglobin content. The changes observed in erythrocytes of RP-treated rats may serve as an additional criterion for evaluation of hypervitaminosis A severity.
authors.forename: T A
authors.initials: TA
authors.lastname: Minashkina
mesh_terms: D000818:Animals; D048430:Cell Shape / Q000187:drug effects; D003593:Cytoplasm / Q000187:drug effects*; D004224:Diterpenes; D004907:Erythrocyte Deformability / Q000187:drug effects; D004910:Erythrocyte Membrane / Q000187:drug effects*; D004912:Erythrocytes / Q000166:cytology / Q000187:drug effects; D006986:Hypervitaminosis A / Q000139:chemically induced*; D008297:Male; D023421:Models, Animal; D009821:Oils / Q000008:administration & dosage; D051381:Rats; D017208:Rats, Wistar; D000084562:Retinyl Esters; D013102:Spherocytes / Q000166:cytology / Q000187:drug effects; D014801:Vitamin A / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*
chemical_list: D004224:Diterpenes; D009821:Oils; D000084562:Retinyl Esters; D014801:Vitamin A; C014794:retinol palmitate